Financial Perspectives’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-310
| Closed | -$241 | – | 732 |
|
|
2024
Q3 | $241 | Hold |
310
| – | – | ﹤0.01% | 654 |
|
|
2024
Q2 | $233 | Hold |
310
| – | – | ﹤0.01% | 652 |
|
|
2024
Q1 | $329 | Hold |
310
| – | – | ﹤0.01% | 637 |
|
|
2023
Q4 | $326 | Hold |
310
| – | – | ﹤0.01% | 664 |
|
|
2023
Q3 | $347 | Hold |
310
| – | – | ﹤0.01% | 670 |
|
|
2023
Q2 | $467 | Hold |
310
| – | – | ﹤0.01% | 647 |
|
|
2023
Q1 | $484 | Hold |
310
| – | – | ﹤0.01% | 646 |
|
|
2022
Q4 | $198 | Hold |
310
| – | – | ﹤0.01% | 663 |
|
|
2022
Q3 | $412 | Hold |
310
| – | – | ﹤0.01% | 660 |
|
|
2022
Q2 | $688 | Hold |
310
| – | – | ﹤0.01% | 642 |
|
|
2022
Q1 | $1.92K | Hold |
310
| – | – | ﹤0.01% | 613 |
|
|
2021
Q4 | $3.91K | Buy |
+310
| New | +$3.91K | ﹤0.01% | 539 |
|